網宿科技(300017.SZ):就增資創而新已完成工商變更登記手續
格隆匯 12 月 16日丨網宿科技(300017.SZ)公佈,2020年10月30日,公司召開第五屆董事會第五次會議、第五屆監事會第四次會議,審議通過《關於終止籌劃發行股份及支付現金購買資產並募集配套資金事項的議案》,同意公司向創而新(北京)教育科技有限公司(“創而新”)增資人民幣1億元,增資後,公司持有創而新的股權比例為16.6667%。
公司已按照《關於創而新(北京)教育科技有限公司之增資協議書》,完成了對創而新增資款的繳付。此次增資完成後,創而新的註冊資本變更為人民幣1935.0876萬元。
目前,創而新已完成工商變更登記手續,並取得了北京市海淀區市場監督管理局換髮的《營業執照》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.